Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)
Clinical trial NCT06886360 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06886360
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-09-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.